Lataa...
Quantitative risk-benefit analysis of natalizumab
OBJECTIVE: To model the long-term risks and benefits of natalizumab in individuals with relapsing multiple sclerosis (MS). METHODS: We created a Markov model to evaluate treatment effects on reducing relapses and slowing disease progression using published natural history data and clinical trial res...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Academy of Neurology
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2676947/ https://ncbi.nlm.nih.gov/pubmed/18663181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/01.wnl.0000319648.65173.7a |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|